Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87001-87050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05327933
Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
NARecruiting
154 participants
Started: May 26, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05317494
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
N/ARecruiting
100 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05412680
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)
NARecruiting
60 participants
Started: May 25, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04863950
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PHASE2Recruiting
25 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05763940
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
NAActive, not recruiting
130 participants
Started: May 25, 2022 · Completed: Jun 25, 2024
3 conditions2 sponsors1 location
NCT05301764
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
65 participants
Started: May 25, 2022 · Completed: Oct 19, 2025
1 condition1 sponsor5 locations
NCT05307289
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NARecruiting
20 participants
Started: May 25, 2022 · Completed: Oct 25, 2028
1 condition1 sponsor1 location
NCT05060289
A Prognostic Model for Drug-induced Liver Injury in China
N/ARecruiting
3,000 participants
Started: May 25, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor13 locations
NCT04961190
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
PHASE4Recruiting
300 participants
Started: May 25, 2022 · Completed: Jul 15, 2026
1 condition9 sponsors7 locations
NCT05277714
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
NARecruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05342584
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
PHASE1Recruiting
99 participants
Started: May 25, 2022 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT05387473
Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis
NAActive, not recruiting
128 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
2 conditions3 sponsors1 location
NCT05333003
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
NARecruiting
92 participants
Started: May 25, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05185492
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
N/ARecruiting
500 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor3 locations
NCT05356104
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
PHASE2Recruiting
110 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05052671
ctDNA Assay in Patients With Resectable Pancreatic Cancer
N/ARecruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT05519046
Cardiac Contractility Modulation in Chagas Heart Disease
NARecruiting
60 participants
Started: May 25, 2022 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT05328856
Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being
NARecruiting
50 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06180876
Effect of Remimazolam on Postoperative Delirium
NARecruiting
190 participants
Started: May 25, 2022 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT05778032
Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)
N/AActive, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05472259
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
PHASE2Recruiting
134 participants
Started: May 25, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors13 locations
NCT04752137
Intraoperative Tumor Margin Identification With ICG Dye Imaging
PHASE2Recruiting
100 participants
Started: May 25, 2022 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT06284473
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
PHASE4Recruiting
108 participants
Started: May 25, 2022 · Completed: May 31, 2028
3 conditions1 sponsor1 location
NCT05434234
A Study of YL201 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
312 participants
Started: May 25, 2022 · Completed: Oct 6, 2027
1 condition1 sponsor45 locations
NCT05144087
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
N/AActive, not recruiting
18 participants
Started: May 25, 2022 · Completed: Nov 30, 2027
1 condition3 sponsors1 location
NCT04629547
Sleep Trial to Prevent Alzheimer's Disease
PHASE2Recruiting
200 participants
Started: May 25, 2022 · Completed: May 31, 2026
2 conditions3 sponsors1 location
NCT06866301
Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study
NAActive, not recruiting
48 participants
Started: May 25, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06063928
Confronting Cancer as a Community
N/ARecruiting
500 participants
Started: May 25, 2022 · Completed: May 25, 2028
1 condition2 sponsors2 locations
NCT06874894
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)
N/AEnrolling by invitation
1,100 participants
Started: May 25, 2022 · Completed: Aug 30, 2026
1 condition7 sponsors1 location
NCT06770621
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
NARecruiting
1,000 participants
Started: May 25, 2022 · Completed: Oct 25, 2025
2 conditions2 sponsors1 location
NCT04423874
The Effect of Exposure to Aversive Non-verbal Vocalizations on Pain Tolerance
NARecruiting
104 participants
Started: May 25, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05356377
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
N/AEnrolling by invitation
13 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT04968015
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
PHASE2Active, not recruiting
134 participants
Started: May 25, 2022 · Completed: Jan 31, 2029
1 condition1 sponsor26 locations
NCT05370547
Chidamide Bridging for CAR-T Therapy
PHASE1/PHASE2Recruiting
120 participants
Started: May 25, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor13 locations
NCT05430178
Metabolic Pathology of Pediatric NAFLD
NARecruiting
100 participants
Started: May 25, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT05392699
ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
PHASE1Recruiting
60 participants
Started: May 25, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05967169
EFS of Bioabsorbable Implant for NSD
NAActive, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 8, 2025
1 condition1 sponsor2 locations
NCT05449106
Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT
N/ARecruiting
200 participants
Started: May 25, 2022 · Completed: May 25, 2032
1 condition4 sponsors4 locations
NCT05518383
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
PHASE4Recruiting
300 participants
Started: May 25, 2022 · Completed: May 16, 2027
5 conditions1 sponsor1 location
NCT05147961
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NARecruiting
300 participants
Started: May 25, 2022 · Completed: Apr 1, 2025
1 condition3 sponsors2 locations
NCT04517656
Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells
NARecruiting
40 participants
Started: May 25, 2022 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT05329935
Congenital Athymia Patient Registry
N/ARecruiting
75 participants
Started: May 25, 2022 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05355025
WiserAD: The Effect of a Structured Online Intervention on Antidepressant Deprescribing in Primary Care
NARecruiting
312 participants
Started: May 25, 2022 · Completed: Aug 7, 2025
1 condition2 sponsors1 location
NCT05338775
A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
74 participants
Started: May 25, 2022 · Completed: May 3, 2027
1 condition1 sponsor19 locations
NCT06148285
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
NARecruiting
120 participants
Started: May 24, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05431257
Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
PHASE2Recruiting
117 participants
Started: May 24, 2022 · Completed: Sep 1, 2031
1 condition14 sponsors1 location
NCT05199584
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
PHASE2Active, not recruiting
44 participants
Started: May 24, 2022 · Completed: May 31, 2024
1 condition1 sponsor16 locations
NCT06328179
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
NARecruiting
34 participants
Started: May 24, 2022 · Completed: Dec 30, 2027
1 condition4 sponsors1 location
NCT05397223
A Study of Modified mRNA Vaccines in Healthy Adults
PHASE1Active, not recruiting
308 participants
Started: May 24, 2022 · Completed: Feb 21, 2026
4 conditions1 sponsor8 locations
NCT04282473
Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh
N/ARecruiting
134 participants
Started: May 24, 2022 · Completed: May 31, 2026
2 conditions1 sponsor16 locations